Published by Frank Prenesti on 9th December 2022
(Sharecast News) - Syncona portfolio company Autolus Therapeutics announced that a phase 2 clinical trial in adult acute lymphoblastic leukemia (ALL) patients has met its primary endpoint at interim analysis.
URL: http://www.digitallook.com/dl/news/story/33167039/...